Liu Z, Cai L, Xing M, Qiao N, Liu J, Li X
Biosaf Health. 2025; 6(3):153-164.
PMID: 40078728
PMC: 11894967.
DOI: 10.1016/j.bsheal.2024.04.001.
Zambrana J, Mellis I, Shotwell A, Maier H, Saborio Y, Barillas C
medRxiv. 2025; .
PMID: 39990561
PMC: 11844606.
DOI: 10.1101/2025.02.11.25322066.
Samiea A, Celis G, Yadav R, Rodda L, Moreau J
Nat Rev Immunol. 2025; .
PMID: 39910240
DOI: 10.1038/s41577-025-01137-6.
Zhou X, Wu Y, Zhu Z, Lu C, Zhang C, Zeng L
Signal Transduct Target Ther. 2025; 10(1):7.
PMID: 39774607
PMC: 11707400.
DOI: 10.1038/s41392-024-02043-4.
Brandi R, Paganelli A, DAmelio R, Giuliani P, Lista F, Salemi S
Vaccines (Basel). 2025; 12(12.
PMID: 39772079
PMC: 11680146.
DOI: 10.3390/vaccines12121418.
STAR LIGHT Study: XBB.1.5 COVID-19 mRNA Vaccines Boost Systemic but Not Mucosal Immunity Against the SARS-CoV-2 JN.1 Variant in Patients with Chronic Liver Disease.
Woelfel S, Junker D, Bergamin I, Meyer-Herbon P, Stillhard R, Graf N
Vaccines (Basel). 2024; 12(11).
PMID: 39591144
PMC: 11598625.
DOI: 10.3390/vaccines12111241.
Reproducibility Assessment of Enzyme-Linked Immunosorbent Assays to Detect Anti-HPV16 L1-Specific IgG1, IgG3, IgA, and IgM Antibodies.
Matsui K, Hempel H, Shelton G, Ocampo R, Kemp T, Pan Y
Vaccines (Basel). 2024; 12(10).
PMID: 39460275
PMC: 11511443.
DOI: 10.3390/vaccines12101108.
Navigating the Landscape of B Cell Mediated Immunity and Antibody Monitoring in SARS-CoV-2 Vaccine Efficacy: Tools, Strategies and Clinical Trial Insights.
OReilly S, Byrne J, Feeney E, Mallon P, Gautier V
Vaccines (Basel). 2024; 12(10).
PMID: 39460256
PMC: 11511438.
DOI: 10.3390/vaccines12101089.
Tissue-resident memory T cells contribute to protection against heterologous SARS-CoV-2 challenge.
Odle A, Kar M, Verma A, Sariol A, Meyerholz D, Suthar M
JCI Insight. 2024; 9(23).
PMID: 39405115
PMC: 11623939.
DOI: 10.1172/jci.insight.184074.
Meeting Report From "Correlates of Protection for Next Generation Influenza Vaccines: Lessons Learned From the COVID-19 Pandemic".
Krammer F, Katz J, Engelhardt O, Post D, Roberts P, Sullivan S
Influenza Other Respir Viruses. 2024; 18(10):e13314.
PMID: 39380156
PMC: 11461279.
DOI: 10.1111/irv.13314.
mRNA vaccines for infectious diseases - advances, challenges and opportunities.
Pardi N, Krammer F
Nat Rev Drug Discov. 2024; 23(11):838-861.
PMID: 39367276
DOI: 10.1038/s41573-024-01042-y.
Impaired mucosal IgA response in patients with severe COVID-19.
Yaugel-Novoa M, Noailly B, Jospin F, Pizzorno A, Traversier A, Pozzetto B
Emerg Microbes Infect. 2024; 13(1):2401940.
PMID: 39358866
PMC: 11451292.
DOI: 10.1080/22221751.2024.2401940.
A Dual-Adjuvanted Parenteral-Intranasal Subunit Nanovaccine generates Robust Systemic and Mucosal Immunity Against SARS-CoV-2 in Mice.
Pandey B, Wang Z, Jimenez A, Bhatia E, Jain R, Beach A
Adv Sci (Weinh). 2024; 11(45):e2402792.
PMID: 39352717
PMC: 11615772.
DOI: 10.1002/advs.202402792.
An intranasally administered adenovirus-vectored SARS-CoV-2 vaccine induces robust mucosal secretory IgA.
Sun B, Wang Q, Zheng P, Niu X, Feng Y, Guan W
JCI Insight. 2024; 9(18).
PMID: 39315545
PMC: 11457852.
DOI: 10.1172/jci.insight.180784.
Intranasal HD-Ad-FS vaccine induces systemic and airway mucosal immunities against SARS-CoV-2 and systemic immunity against SARS-CoV-2 variants in mice and hamsters.
Zhou P, Watt J, Mai J, Cao H, Li Z, Chen Z
Front Immunol. 2024; 15:1430928.
PMID: 39281669
PMC: 11392758.
DOI: 10.3389/fimmu.2024.1430928.
Early, Robust Mucosal Secretory Immunoglobulin A but not Immunoglobulin G Response to Severe Acute Respiratory Syndrome Coronavirus 2 Spike in Oral Fluid Is Associated With Faster Viral Clearance and Coronavirus Disease 2019 Symptom Resolution.
Pisanic N, Antar A, Hetrich M, Demko Z, Zhang X, Spicer K
J Infect Dis. 2024; 231(1):121-130.
PMID: 39269503
PMC: 11793072.
DOI: 10.1093/infdis/jiae447.
MVA-based vaccine candidates expressing SARS-CoV-2 prefusion-stabilized spike proteins of the Wuhan, Beta or Omicron BA.1 variants protect transgenic K18-hACE2 mice against Omicron infection and elicit robust and broad specific humoral and cellular....
Perez P, Astorgano D, Albericio G, Flores S, Sanchez-Corzo C, Noriega M
Front Immunol. 2024; 15:1420304.
PMID: 39267752
PMC: 11390564.
DOI: 10.3389/fimmu.2024.1420304.
COVID-19 mRNA Vaccines Induce Robust Levels of IgG but Limited Amounts of IgA Within the Oronasopharynx of Young Children.
Tang Y, Boribong B, Swank Z, Demokritou M, Luban M, Fasano A
J Infect Dis. 2024; 230(6):1390-1399.
PMID: 39253950
PMC: 11646609.
DOI: 10.1093/infdis/jiae450.
Robust immune response to COVID-19 vaccination in the island population of Greenland.
Moller M, Friis-Hansen L, Kirkby N, Dilling-Hansen C, Andersson M, Vedsted P
Commun Med (Lond). 2024; 4(1):173.
PMID: 39242878
PMC: 11379896.
DOI: 10.1038/s43856-024-00602-y.
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primates.
Gagne M, Flynn B, Andrew S, Marquez J, Flebbe D, Mychalowych A
Nat Immunol. 2024; 25(10):1913-1927.
PMID: 39227514
PMC: 11436372.
DOI: 10.1038/s41590-024-01951-5.
